5- ((4- (4- (diisobutylamino)butyl)- 1- phenyl)acetyl)- 10,11- dihydro- 5H- dibenzo(b,e)(1,4)diazepin- 11- one

a muscarinic receptor ligand; penetrates the blood brain barrier; has high in vivo selectivity for the m2 subtype; structure given in first source

Also Known As:

DIBD

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Carlson, Gabrielle A: 1 article (01/2003)
2.	Mick, Eric: 1 article (01/2003)

1.	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/01/2003 - "Attention deficit hyperactivity disorder, pervasive developmental disorder, and selective serotonin reuptake inhibitor use appeared to increase the risk, and older age and stimulant use decreased the risk of DIBD. "

1.	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)